Get started
Author

Anna Teresa Mazzeo

Observed names: A Mazzeo, A. MAZZEO, A. Mazzeo, A. T. Mazzeo, Anna Mazzeo, Anna T Mazzeo, Mazzeo, Anna, Mazzeo, Anna Teresa
Observed institutions: University of Messina, Johns Hopkins University, University of Milan, University of Pavia, Johns Hopkins Medicine, Maastricht University Medical Centre, Hospital Universitario 12 De Octubre, IRCCS Ospedale San Raffaele, Azienda Ospedaliera Universitaria Policlinico "G. Martino", Fondazione Toscana Gabriele Monasterio, Fondazione IRCCS Istituto Neurologico Carlo Besta, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele, UCL Queen Square Institute of Neurology, University College London, University of Milano-Bicocca, University of Naples Federico II, Columbia University, University of Genoa
ORCID: 0000-0003-1914-6184
Observed ORCIDs: 0000-0003-1914-6184, 0000-0002-8454-7243
OpenAlex ID: A5077159353
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
2012 · G. Cavaletti, G. Cavaletti, et al. · Annals of Oncology · 293
PDF
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy
2023 · Teresa Coelho, Wilson Marques, et al. · JAMA · 245
PDF
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP
2019 · Andrea Cortese, Raffaella Lombardi, et al. · Neurology Neuroimmunology & Neuroinflammation · 182
PDF
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
2013 · P. Alberti, E. Rossi, et al. · Annals of Oncology · 180
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy
2003 · M.C. Monici, M. Aguennouz, et al. · Neurology · 176
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
2020 · David Adams, Michael Polydefkis, et al. · The Lancet Neurology · 159
A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy
2009 · D. Cocito, I. Paolasso, et al. · European Journal of Neurology · 149
Hereditary transthyretin amyloidosis overview
2020 · Fiore Manganelli, Gian Maria Fabrizi, et al. · Neurological Sciences · 124
PDF
Lipid Peroxidation Inhibition Blunts Nuclear Factor-κB Activation, Reduces Skeletal Muscle Degeneration, and Enhances Muscle Function in mdx Mice
2006 · Sonia Messina, Domenica Altavilla, et al. · American Journal Of Pathology · 118
PDF
VEGF overexpression via adeno‐associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice
2007 · Sonia Messina, Anna Mazzeo, et al. · The FASEB Journal · 107
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area
2016 · A. Cortese, G. Vita, et al. · Journal of Neurology · 100
PDF
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area
2015 · Anna Mazzeo, Massimo Russo, et al. · Journal of Neuromuscular Diseases · 95
PDF
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation
2020 · Francesco Cappelli, Giacomo Tini, et al. · Amyloid · 94
ATTRv amyloidosis Italian Registry: clinical and epidemiological data
2020 · Massimo Russo, Laura Obici, et al. · Amyloid · 88
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
2023 · Luca Gentile, Teresa Coelho, et al. · Orphanet Journal of Rare Diseases · 83
PDF
Oxidative stress causes nuclear factor-κB activation in acute hypovolemic hemorrhagic shock
2001 · Domenica Altavilla, Antonino Saitta, et al. · Free Radical Biology and Medicine · 71
MRI of Cardiac Involvement in Transthyretin Familial Amyloid Polyneuropathy
2010 · Gianluca Di Bella, Fabio Minutoli, et al. · American Journal of Roentgenology · 69
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: A comparison study with methylprednisolone
2009 · Sonia Messina, Alessandra Bitto, et al. · Experimental Neurology · 66
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study
2014 · SCIg and Chronic Dysimmune Neuropathies Italian Network, Dario Cocito, et al. · Journal of Neurology · 65
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers
2020 · Alessandro Salvalaggio, Daniele Coraci, et al. · Journal of Neurology · 63
PDF
RAGE-NF-?B pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy
2006 · V. Macaione, M. Aguennouz, et al. · Acta Neurologica Scandinavica · 62
PDF
Myopathy as the Persistently Isolated Symptomatology of Primary Autoimmune Hypothyroidism
1998 · C. RODOLICO, A. TOSCANO, et al. · Thyroid · 60
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation
2022 · Hartmut H. Schmidt, Jonas Wixner, et al. · American Journal of Transplantation · 59
PDF
Endocardial and Epicardial Deformations in Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
2011 · Gianluca Di Bella, Fabio Minutoli, et al. · Circulation Journal · 58
PDF
Expanding the spectrum of genes responsible for hereditary motor neuropathies
2019 · Stefano C. Previtali, Edward Zhao, et al. · Journal of Neurology Neurosurgery & Psychiatry · 54
PDF
Works count: 184
Citation count: 4,644
H-index: 38
I10-index: 94
Year
Topic
Type